Filing Details
- Accession Number:
- 0001209191-13-037650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-23 19:00:30
- Reporting Period:
- 2013-07-22
- Filing Date:
- 2013-07-23
- Accepted Time:
- 2013-07-23 19:00:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1333248 | Cadence Pharmaceuticals Inc | CADX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557146 | Malcolm Lloyd-Smith | 12481 High Bluff Dr. Ste. 200 San Diego CA 92130 | Svp, Reg Affairs, Qual & Clin | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-22 | 14,000 | $3.51 | 16,332 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-22 | 14,000 | $7.85 | 2,332 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | stock option (right to buy) | Disposition | 2013-07-22 | 14,000 | $0.00 | 14,000 | $3.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,338 | 2012-09-14 | 2022-03-14 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2013.
- Not applicable to this transaction.